September 2022 tender notification

Medicines Tender Closed

Pharmac is pleased to provide the latest tender results.

Tender results

Pharmac has resolved to award tenders for Principal Supply Status for some products included in the 2021/22 Invitation to Tender (ITT) dated 1 November 2021.

Some of the pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with Pharmac. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. Pharmac will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to Pharmac, the Pharmacy Guild and the NZULM by:

  • For new listings, by 4pm on 12 October 2022 or the 5th of the month prior to listing, whichever is earlier
  • For price changes, by 4pm on the 12th of the month prior to the date of subsidy change

Pharmac cannot list a product (and pharmacies cannot claim) without this information. 

More information about this process and NOPC forms can be found on our website.

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link)  and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link).

Pharmacodes and CTPP codes must be provided to Pharmac by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest).

Pharmac cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

CORRECTION to September 2022 Tender Notification

The September 2022 tender notification notified the incorrect price for ‘enalapril – tab 5 mg’

Corrections in bold and strikethrough below.

2021/22 Tender – Principal Supply Status applies until 30 June 2025

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

The decisions were as follows:

1.  Tenders awarded to currently listed Pharmaceuticals where no other brand is listed

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Principal Supply brand
(Supplier)

Date of subsidy change

Principal Supply date

Ceftriaxone

Inj 500 mg vial; 1 vial pack

$0.89

$0.79

Ceftriaxone-AFT (AFT)

1 November 2022

1 April 2023

Ceftriaxone

Inj 1 g; 5 vial pack

$3.99

$3.59

Ceftriaxone-AFT (AFT)

1 November 2022

1 April 2023

Progesterone1

Capsule 100 mg, 30 capsule blister pack

$16.50

$14.85

Utrogestan
(Pharmaco)

1 December 2022

1 May 2023

1 Progesterone capsules will be funded without restrictions from 1 December 2022.

 

2.  Tenders awarded to Pharmaceuticals where at least one other brand is listed.

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Principal Supply brand (Supplier)

Date of listing

Principal Supply Status date

Brand
(Supplier)
affected by delisting

Codeine phosphate

Tab 30 mg; 100 tablet blister pack

$7.45

$32.80

$6.98

Noumed (Noumed)

1 November 2022

1 April 2023

PSM (API Consumer Brands)

Aspen (Aspen)

Codeine phosphate

Tab 60 mg; 100 tablet blister pack

$14.25

$13.89

Noumed (Noumed)

1 November 2022

1 April 2023

PSM (API Consumer Brands)

Chlortalidone [chlorthalidone]

Tab 25 mg; 50 tablet bottle

$6.50 (per 50)

$3.90 (per 30)

$6.95

Hygroton (AFT)

1 November 2022

1 April 2023

Igroton (AFT)

Clindamycin

Inj 150 mg per ml, 4 ml ampoule; 10 ampoule pack

$39.00

$35.10

Hameln (Max Health)

1 March 2023

1 August 2023

Dalacin C (Pfizer)

Enalapril maleate

Tab 5 mg; 90 tablet bottle

$1.82
(per 100)

$2.74 $1.75

Acetec (Viatris)

1 April 2023

1 September 2023

Acetec (Viatris)

Pharmacode 2572230

Enalapril maleate

Tab 10 mg; 90 tablet bottle

$2.02
(per 100)

$1.97

Acetec (Viatris)

1 April 2023

1 September 2023

Acetec (Viatris)
Pharmacode 2572249

Enalapril maleate

Tab 20 mg; 90 tablet bottle

$2.42
(per 100)

$2.35

Acetec (Viatris)

1 April 2023

1 September 2023

Acetec (Viatris)
Pharmacode 2572257

Sumatriptan

Inj 12 mg per ml, 0.5 ml prefilled pen; 2 pen OP

$34.00

$29.80

Clustran (Douglas)

1 April 2023

1 September 2023

Imigran (GSK)

Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule

3.  Tenders awarded to currently listed Pharmaceuticals where no other brand is listed

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Principal Supply brand
(Supplier)

DV Limit

Date of subsidy change

Principal Supply date

Ceftriaxone

Inj 500 mg; 1 vial pack

$0.89

$0.79

Ceftriaxone-AFT (AFT)

5%

1 November 2022

1 April 2023

Ceftriaxone

Inj 1 g; 5 vial pack

$3.99

$3.59

Ceftriaxone-AFT (AFT)

5%

1 November 2022

1 April 2023

Chlortalidone [chlorthalidone]

Tab 25 mg; 50 tablet bottle

$6.50

$6.95

Hygroton (AFT)

5%

1 November 2022

1 April 2023

Progesterone2

Capsule 100 mg, 30 capsule blister pack

$16.50

$14.85

Utrogestan
(Pharmaco)

5%

1 December 2022

1 May 2023

2 Progesterone capsules will be funded without restrictions from 1 December 2022

4.  Tenders awarded to currently listed Pharmaceuticals where at least one other brand is listed

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Principal Supply brand (Supplier)

DV Limit

Listing date

Principal Supply Status date

Brand
(Supplier)
affected by delisting

Codeine phosphate

Tab 30 mg; 100 tablet blister pack

$7.45

$32.80

$6.98

Noumed (Noumed)

5%

1 November 2022

1 April 2023

PSM (API Consumer Brands)

Aspen (Aspen)

Codeine phosphate

Tab 60 mg; 100 tablet blister pack

$14.25

$13.89

Noumed (Noumed)

5%

1 November 2022

1 April 2023

PSM (API Consumer Brands)

Ceftriaxone

Inj 2 g; 5 vial pack

$1.98
(per 1)

$7.85

Ceftriaxone-AFT

5%

1 March 2023

1 August 2023

Ceftriaxone-AFT (AFT)
Pharmacode 2400847

Clindamycin

Inj 150 mg per ml, 4 ml ampoule; 10 ampoule pack

$39.00

$35.10

Hameln (Max Health)

5%

1 March 2023

1 August 2023

Dalacin C (Pfizer)

Enalapril maleate

Tab 5 mg; 90 tablet bottle

$1.82
(per 100)

$2.74 $1.75

Acetec (Viatris)

5%

1 April 2023

1 September 2023

Acetec (Viatris)

Pharmacode 2572230

Enalapril maleate

Tab 10 mg; 90 tablet bottle

$2.02
(per 100)

$1.97

Acetec (Viatris)

5%

1 April 2023

1 September 2023

Acetec (Viatris)
Pharmacode 2572249

Enalapril maleate

Tab 20 mg; 90 tablet bottle

$2.42
(per 100)

$2.35

Acetec (Viatris)

5%

1 April 2023

1 September 2023

Acetec (Viatris)
Pharmacode 2572257

Sumatriptan

Inj 12 mg per ml, 0.5 ml prefilled pen; 2 pen OP

$34.00

$29.80

Clustran (Douglas)

5%

1 April 2023

1 September 2023

Imigran (GSK)

Tender declines - Products where no tender is to be awarded for Principal Supply Status

Pharmac has resolved not to award tenders for Principal Supply Status for the following products listed in the:

  • 2019/20 Invitation to Tender, dated 1 November 2019;
  • 2020/21 Invitation to Tender, dated 2 November 2020; and the
  • 2021/22 Invitation to Tender, dated 1 November 2021.

 

2019/20 Invitation to Tender

Chemical name

Line item

Ephedrine

Inj 3 mg per ml, 10 ml prefilled syringe

Noradrenaline

Inj 0.06 mg per ml, 50 ml vial

Noradrenaline

Inj 0.1 mg per ml, 50 ml syringe

Noradrenaline

Inj 0.12 mg per ml, 50 ml vial

 

2020/21 Invitation to Tender

Chemical name

Line item

Felodipine

Tab long-acting 2.5 mg

Vecuronium

Inj 10 mg

 

2021/22 Invitation to Tender

Chemical name

Line item

Atomoxetine

Cap 10 mg

Atomoxetine

Cap 18 mg

Atomoxetine

Cap 25 mg

Atomoxetine

Cap 40 mg

Atomoxetine

Cap 60 mg

Atomoxetine

Cap 80 mg

Clobazam

Liq

Coal tar

Soln BP

Compound hydroxybenzoate

Soln

Fentanyl

Inj 10 mcg per ml, 100 ml premixed bag

Glycerin with sodium saccharin

Suspension

Glycerin with sucrose

Suspension

Methylhydroxybenzoate

Powder

Progesterone (current access)

Cap 100 mg

Pyridostigmine bromide

Tab 60 mg

Sodium bicarbonate

Powder BP

Syrup (pharmaceutical grade)

Liq

Zinc and castor oil

Oint (pack size 50 g or less)

For products included in the 2019/20, 2020/21 or 2021/22 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.

If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.